SH2 domain-containing signaling proteins in human breast cancer

Breast Cancer Research and Treatment

Volumn 34, Issue 1, 1995, Pages 85-92

  Daly, Roger J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

breast cancer; signal transduction; tyrosine kinase

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PHOSPHOLIPASE C; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RAS PROTEIN;

BREAST CANCER; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CONSERVED SEQUENCE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; ISOENZYMES; PHOSPHOLIPASE C; PROTEIN-TYROSINE KINASE; PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0028906763     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF00666495     Document Type: Review

References (62)

1. Control of human breast cancer by estrogen, growth factors and oncogenes
2. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer
3. Epidermal-growth-factor receptor status as predictor of early recurrence and death from breast cancer
4. Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer
5. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice
6. Single step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
7. Overexpression of TGF-α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia and carcinoma of the breast
8. Growth factor signaling by receptor tyrosine kinases
9. SH2 and SH3 domains
10. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
11. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on ras
12. Molecular cloning of the mouse grb2 gene: Differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors
13. The function of GRB2 in linking the insulin receptor to ras signaling pathways
14. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
15. The SH2- and SH3-containing Nck protein transforms mammalian fibroblasts in the absence of elevated phosphotyrosine levels
16. The cell cycle and c-Src
17. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase Cγ
18. Nonreceptor tyrosine protein kinases
19. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the ras pathway by tyrosine kinases
20. The v-Src SH3 domain binds phosphatidyl 3′-kinase
21. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases
22. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation
23. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v- src substrate and is located in cell-substratum contact sites
24. Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas
25. Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues
26. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue
27. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c- src oncogene product
28. Association between the PDGF receptor and members of the Src family of tyrosine kinases
29. Involvement of pp60c-src with two major signaling pathways in human breast cancer
30. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity
31. Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src
32. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of pp60c-src
33. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase
34. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease
35. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice
36. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling
37. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase Cγ
38. The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-γ and GTPase-activating protein does not correlate with erbB-2 mitogenic potency
39. Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation
40. Elevated content of the tyrosine kinase substrate phospholipase C-γ1 in primary human breast carcinomas
41. Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C
42. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal
43. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis
44. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis
45. Effect of phospholipase C-γ overexpression on PDGF-induced second messengers and mitogenesis
46. Immunocytochemical localization of phospholipase Cγ in rat embryo fibroblasts
47. Signal transduction via the MAP kinases: proceed at your own RSK
48. The mitogen-activated protein kinase signal transduction pathway
49. Requirements for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
50. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells
51. Activation of the Ras signaling pathway in human breast cancer cell lines overexpressing erbB-2
52. Overexpression of the Grb2 gene in human breast cancer cell lines
53. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
54. High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with src homology 2 domains
55. The PH domain: a common piece in the structural patchwork of signaling proteins
56. The binding site for the βγsubunits of heterotrimeric G proteins on the β-adrenergic receptor kinase
57. Binding of G protein βγ-subunits to pleckstrin homology domains
58. The SH2 domain containing protein GRB-7 is coamplified, overexpressed and in a tight complex with HER2 in breast cancer
59. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis
60. Somatic mutations in the neurofibromatosis 1 gene in human tumours
61. Nonsense mutations in the C-terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours
62. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein